Method and system for routing calls over a packet switched computer network
    31.
    发明申请
    Method and system for routing calls over a packet switched computer network 有权
    通过分组交换计算机网络路由呼叫的方法和系统

    公开(公告)号:US20050201364A1

    公开(公告)日:2005-09-15

    申请号:US11075040

    申请日:2005-03-08

    CPC classification number: H04L65/1046 H04L45/00 H04L47/10 H04L47/2416

    Abstract: The present invention describes how a trusted network routing authority, such as a VoIP inter-exchange carrier or clearinghouse can provide routing and secure access control across multiple network domains with a single routing and admission request. This technology can improve network efficiency and quality of service when an Internet Protocol (IP) communication transaction, such as a Voice over IP (VoIP), must be routed across multiple devices or administrative domains. This technology defines the technique of performing multiple route look-ups at the source of the call path to determine all possible routes across intermediate domains to the final destination. The VoIP inter-exchange carrier or clearinghouse then provides routing and access permission tokens for the entire call path to the call source.

    Abstract translation: 本发明描述了诸如VoIP交换运营商或结算所之类的信任网络路由机构如何通过单个路由和接纳请求来提供跨多个网络域的路由和安全访问控制。 当诸如IP语音(VoIP)的因特网协议(IP)通信事务必须跨多个设备或管理域路由时,该技术可以提高网络效率和服务质量。 该技术定义了在呼叫路径的源处执行多个路由查找以确定跨越中间域到最终目的地的所有可能路由的技术。 然后,VoIP交换运营商或交换中心为呼叫源的整个呼叫路径提供路由和访问权限令牌。

    Haloacetamide and azide substituted compounds and methods of use thereof
    32.
    发明申请
    Haloacetamide and azide substituted compounds and methods of use thereof 审中-公开
    卤代乙酰胺和叠氮化物取代的化合物及其使用方法

    公开(公告)号:US20050137172A1

    公开(公告)日:2005-06-23

    申请号:US10963761

    申请日:2004-10-14

    CPC classification number: C07D207/452 C07C235/24 C07C255/60

    Abstract: The present invention relates to a novel class of anti-cancer compounds, which contain a haloacetamide or azide moiety and are, in one embodiment, alkylating agents. These agents, either alone or in a composition, are useful for treating cancer, preventing cancer, delaying the progression of cancer, treating and/or preventing the recurrence of cancer, suppressing, inhibiting or reducing the incidence of cancer, or inducing apoptosis in a cancer cell. Accordingly, the present invention provides a) methods of treating cancer in a subject; b) methods of preventing cancer in a subject; c) methods of delaying the progression of cancer in a subject; d) methods of treating the recurrence of cancer in a subject; e) methods of preventing the recurrence of cancer in a subject; f) methods of suppressing, inhibiting or reducing the incidence of cancer in a subject; and g) methods of inducing apoptosis in a cancer cell; by administering to the subject an anti-cancer compound of the present invention or an analog or metabolite thereof, its N-oxide, ester, pharmaceutically acceptable salt, hydrate, or any combination thereof as described herein.

    Abstract translation: 本发明涉及一类新的抗癌化合物,其含有卤代乙酰胺或叠氮化物部分,在一个实施方案中是烷化剂。 这些药物单独或组合物可用于治疗癌症,预防癌症,延缓癌症进展,治疗和/或预防癌症复发,抑制,抑制或降低癌症发生率或诱导癌细胞凋亡 癌细胞。 因此,本发明提供了a)在受试者中治疗癌症的方法; b)预防受试者癌症的方法; c)延缓受试者癌症进展的方法; d)治疗患者癌症复发的方法; e)预防受试者癌症复发的方法; f)抑制或抑制受试者癌症发病率的方法; 和g)诱导癌细胞凋亡的方法; 通过向受试者施用本文所述的抗癌化合物或其类似物或代谢物,其N-氧化物,酯,药学上可接受的盐,水合物或其任何组合。

    Treating androgen decline in aging male (ADAM)-associated conditions with SARMS
    33.
    发明申请
    Treating androgen decline in aging male (ADAM)-associated conditions with SARMS 审中-公开
    老年男性(ADAM)治疗雄激素相关性SARS的病情下降

    公开(公告)号:US20050080054A1

    公开(公告)日:2005-04-14

    申请号:US10683161

    申请日:2003-10-14

    CPC classification number: C07K14/721

    Abstract: The present invention provides a method of treating, preventing, suppressing, inhibiting or reducing the incidence of an Androgen Decline in Aging Male (ADAM)-associated condition in a male subject, by administering to the subject a selective androgen receptor modulator (SARM) compound and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, crystal, or any combination thereof. The present invention further provides a method of treating, preventing, suppressing, inhibiting or reducing the incidence of sexual dysfunction, decreased sexual libido, erectile dysfunction, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, benign prostate hyperplasia or prostate cancer due to ADAM in a male subject, by administering to the subject a selective androgen receptor modulator (SARM) compound and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, crystal, or any combination thereof.

    Abstract translation: 本发明提供了通过向受试者施用选择性雄激素受体调节剂(SARM)化合物,治疗,预防,抑制,抑制或降低男性受试者的老年男性(ADAM)相关状态的雄激素下降的发生率的方法 和/或其类似物,衍生物,异构体,代谢物,药学上可接受的盐,药物产品,水合物,N-氧化物,前药,多晶型物,晶体或其任何组合。 本发明还提供了治疗,预防,抑制或降低性功能障碍,性欲降低,勃起功能障碍,性腺机能减退,肌肉减少症,骨质减少症,骨质疏松症,认知和情绪改变,抑郁症,贫血,脱发 通过向受试者施用选择性雄激素受体调节剂(SARM)化合物和/或其类似物,衍生物,异构体,代谢产物,药学上可接受的盐,药物产品,由此引起的ADAM在男性受试者中的肥胖,良性前列腺增生或前列腺癌。 水合物,N-氧化物,前药,多晶型物,晶体或其任何组合。

    Articulated light transmitting transparent cover apparatus

    公开(公告)号:US12193548B2

    公开(公告)日:2025-01-14

    申请号:US17842710

    申请日:2022-06-16

    Applicant: James Dalton

    Inventor: James Dalton

    Abstract: Broadly, the present invention is of an articulated light transmitting cover apparatus adapted to attach to an article with a display, the cover apparatus including a light transmitting planar cover that is adapted to be removably adjacent to the article display, the light transmitting cover having a cover lengthwise axis and a perpendicularly positioned cover crosswise axis, further the light transmitting cover has a cover primary margin and an opposing cover secondary margin with the cover lengthwise axis spanning therebetween, in addition the light transmitting cover has a cover initial end portion and an opposing cover subsequent end portion with the cover crosswise axis spanning therebetween.

    Isotope-modified hafnium and semiconductor dielectrics

    公开(公告)号:US11929421B2

    公开(公告)日:2024-03-12

    申请号:US17232016

    申请日:2021-04-15

    CPC classification number: H01L29/517 H01G4/10 H01L28/60 C01G27/02

    Abstract: Various methods and systems are provided for facilitating the creation of a new and potentially thinner form of dielectric. Alternatively, for a given capacitance, a thicker layer can be created with lower risk of leakage. The present disclosure will enable the creation of physically smaller electronic components. Isotope-Modified Hafnium Dielectric is used to create a dielectric layer with a greater range of dielectric coefficients, which may enable the creation of smaller and/or more reliable electronic components.

    Dicentra plant named ‘White Gold’
    39.
    植物专利
    Dicentra plant named ‘White Gold’ 有权
    Dicentra植物名为“白金”

    公开(公告)号:USPP27638P3

    公开(公告)日:2017-01-31

    申请号:US14545245

    申请日:2015-04-13

    CPC classification number: A01H5/02

    Abstract: A new and distinct form of Dicentra plant characterized by soft, golden to yellow green foliage, large white flowers, and excellent vigor.

    Abstract translation: 一种新颖独特的Dicentra植物,其特点是柔软,金黄色的绿色叶子,大白花和优秀的活力。

Patent Agency Ranking